"High grade serous ovarian cancer" trang 1 - tải miễn phí từ tailieunhanh
Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer

Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer
18    49    1
Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer

Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer
13    49    1
Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients

Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients
7    53    1
Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer

Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer
11    55    0
Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma

Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
12    1    1
Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma

Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma
14    26    1
Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
8    30    1
Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma

Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma
10    71    1
Intra-tumor heterogeneity in TP53 null high grade serous ovarian carcinoma progression

Intra-tumor heterogeneity in TP53 null high grade serous ovarian carcinoma progression
11    33    1
Mutation landscape of germline and somatic BRCA1/2 in patients with highgrade serous ovarian cancer

Mutation landscape of germline and somatic BRCA1/2 in patients with highgrade serous ovarian cancer
8    52    0
Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma

Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma
11    58    0
Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer

Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer
9    62    0
The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer

The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer
6    63    0
Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential

Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential
13    74    1
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stemlike cells that predicts chemoresistance and poor prognosis

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stemlike cells that predicts chemoresistance and poor prognosis
11    101    1
Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing

Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing
9    38    1
Identification of the IGF1/PI3K/NFκB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer

Identification of the IGF1/PI3K/NFκB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer
11    40    1
Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: A case comparison study

Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: A case comparison study
9    38    1
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer

Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer
10    7    1
Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations
8    37    1